Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Dotatate-gallium-Ga-68 | hsa03020 | RNA polymerase | 4.40E-02 | 2 | P24928, P62487 | POLR2A, POLR2G | More | | Dotatate-gallium-Ga-68 | hsa04022 | cGMP-PKG signaling pathway | 2.55E-02 | 4 | P18848, Q8WYR1, P05141, P0DP24 | ATF4, PIK3R5, SLC25A5, CALM2 | More | | Dotatate-gallium-Ga-68 | hsa04060 | Cytokine-cytokine receptor interaction | 1.74E-02 | 7 | Q9UHF4, P16871, Q9UBD3, P47992, P02775, P32248, P51684 | IL20RA, IL7R, XCL2, XCL1, PPBP, CCR7, CCR6 | More | | Dotatate-gallium-Ga-68 | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 7.74E-04 | 6 | P51684, P32248, P02775, P47992, Q9UBD3, Q9UHF4 | CCR6, CCR7, PPBP, XCL1, XCL2, IL20RA | More | | Dotatate-gallium-Ga-68 | hsa04066 | HIF-1 signaling pathway | 3.40E-02 | 3 | Q09472, P07195, P10415 | EP300, LDHB, BCL2 | More | | Dotatate-gallium-Ga-68 | hsa04110 | Cell cycle | 2.06E-02 | 6 | Q9UJX4, O60566, Q09472, P24522, P04637, P49918 | ANAPC5, BUB1B, EP300, GADD45A, TP53, CDKN1C | More | | Dotatate-gallium-Ga-68 | hsa04151 | PI3K-Akt signaling pathway | 7.39E-03 | 7 | P62753, O43521, P27348, Q8WYR1, P18848, O00141, Q6ZUJ8 | RPS6, BCL2L11, YWHAQ, PIK3R5, ATF4, SGK, PIK3AP1 | More | | Dotatate-gallium-Ga-68 | hsa04210 | Apoptosis | 2.44E-04 | 10 | P04637, P10415, O75460, P24522, Q13077, O43521, P43234, Q9UBR2, P18848, Q14643 | TP53, BCL2, ERN1, GADD45A, TRAF1, BCL2L11, CTSO, CTSZ, ATF4, ITPR1 | More | | Dotatate-gallium-Ga-68 | hsa04217 | Necroptosis | 5.66E-03 | 5 | P15104, P05141, P01584, P0C0S5, Q9H444 | GLUL, SLC25A5, IL1B, H2AFZ, CHMP4B | More | | Dotatate-gallium-Ga-68 | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | | Dotatate-gallium-Ga-68 | hsa04612 | Antigen processing and presentation | 1.64E-02 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Dotatate-gallium-Ga-68 | hsa04613 | Neutrophil extracellular trap formation | 2.17E-02 | 13 | O60603, P05164, P08246, Q9UM07, Q13547, Q92769, Q15080, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, HDAC1, HDAC2, NCF4, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Dotatate-gallium-Ga-68 | hsa04614 | Renin-angiotensin system | 1.52E-02 | 1 | P50052 | AGTR2 | More | | Dotatate-gallium-Ga-68 | hsa04625 | C-type lectin receptor signaling pathway | 4.80E-02 | 6 | Q9ULY5, P20749, Q14643, P01375, Q13191, Q16539 | CLEC4E, BCL3, ITPR1, TNF, CBLB, MAPK14 | More | | Dotatate-gallium-Ga-68 | hsa04640 | Hematopoietic cell lineage | 2.52E-02 | 9 | P13612, P14778, P27930, P15144, P11836, P09693, P01732, P13765, P01375 | ITGA4, IL1R1, IL1R2, ANPEP, MS4A1, CD3G, CD8A, HLA-DOB, TNF | More | | Dotatate-gallium-Ga-68 | hsa04650 | Natural killer cell mediated cytotoxicity | 1.88E-02 | 9 | P01375, P78314, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, SH3BP2, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Dotatate-gallium-Ga-68 | hsa04657 | IL-17 signaling pathway | 2.81E-02 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Dotatate-gallium-Ga-68 | hsa04658 | Th1 and Th2 cell differentiation | 7.47E-03 | 8 | Q04759, P20963, P09693, Q16539, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, MAPK14, STAT4, GATA3, TBX21, HLA-DOB | More | | Dotatate-gallium-Ga-68 | hsa04659 | Th17 cell differentiation | 3.13E-02 | 8 | Q04759, Q16539, P13765, P14778, Q9UL17, P23771, P09693, P20963 | PRKCQ, MAPK14, HLA-DOB, IL1R1, TBX21, GATA3, CD3G, CD247 | More | | Dotatate-gallium-Ga-68 | hsa04660 | T cell receptor signaling pathway | 8.00E-03 | 10 | P01375, Q04759, O95267, Q08881, P20963, P09693, P01732, Q13191, Q16539, P49841 | TNF, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, MAPK14, GSK3B | More | | Dotatate-gallium-Ga-68 | hsa04668 | TNF signaling pathway | 2.91E-02 | 3 | P18848, P01584, P20333 | ATF4, IL1B, TNFRSF1B | More | | Dotatate-gallium-Ga-68 | hsa04912 | GnRH signaling pathway | 4.72E-02 | 4 | Q16539, Q9Y6R4, Q14643, P22694 | MAPK14, MAP3K4, ITPR1, PRKACB | More | | Dotatate-gallium-Ga-68 | hsa04920 | Adipocytokine signaling pathway | 4.72E-02 | 4 | P33121, Q04759, Q9Y4H2, P01375 | ACSL1, PRKCQ, IRS2, TNF | More | | Dotatate-gallium-Ga-68 | hsa04932 | Non-alcoholic fatty liver disease | 2.05E-03 | 5 | O43521, P18848, O75460, P01584, P13073 | BCL2L11, ATF4, ERN1, IL1B, COX4I1 | More | | Dotatate-gallium-Ga-68 | hsa05010 | Alzheimer disease | 2.78E-02 | 6 | P13073, O75460, P0DP24, P01584, P18848, P05141 | COX4I1, ERN1, CALM2, IL1B, ATF4, SLC25A5 | More | | Dotatate-gallium-Ga-68 | hsa05012 | Parkinson disease | 3.89E-02 | 5 | P13073, P05141, O75460, P18848, P0DP24 | COX4I1, SLC25A5, ERN1, ATF4, CALM2 | More | | Dotatate-gallium-Ga-68 | hsa05016 | Huntington disease | 4.87E-02 | 5 | P13073, P24928, P62487, P05141, O75460 | COX4I1, POLR2A, POLR2G, SLC25A5, ERN1 | More | | Dotatate-gallium-Ga-68 | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.98E-02 | 7 | P13073, O75460, P18848, P05141, P20333, P01584, P0DP24 | COX4I1, ERN1, ATF4, SLC25A5, TNFRSF1B, IL1B, CALM2 | More | | Dotatate-gallium-Ga-68 | hsa05140 | Leishmaniasis | 1.31E-02 | 7 | P13612, O75015, P13765, O60603, P01375, Q16539, Q15080 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, MAPK14, NCF4 | More | | Dotatate-gallium-Ga-68 | hsa05144 | Malaria | 1.54E-02 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Dotatate-gallium-Ga-68 | hsa05146 | Amoebiasis | 7.47E-03 | 8 | P09341, P14778, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Dotatate-gallium-Ga-68 | hsa05169 | Epstein-Barr virus infection | 2.71E-02 | 6 | P13765, P04637, P10415, P24522, P29728, P09693 | HLA-DOB, TP53, BCL2, GADD45A, OAS2, CD3G | More | | Dotatate-gallium-Ga-68 | hsa05200 | Pathways in cancer | 4.87E-02 | 9 | P04637, Q9UJU2, Q09472, P14923, P10415, Q13077, O95267, P24522, P16871 | TP53, LEF1, EP300, JUP, BCL2, TRAF1, RASGRP1, GADD45A, IL7R | More | | Dotatate-gallium-Ga-68 | hsa05202 | Transcriptional misregulation in cancer | 2.12E-04 | 19 | Q15532, P41732, P14780, P27930, P14923, Q16548, Q13077, O15550, P04637, P35226, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, Q92769, P12980, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, TRAF1, UTX, TP53, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, HDAC2, LYL1, GADD45A | More | | Dotatate-gallium-Ga-68 | hsa05210 | Colorectal cancer | 2.41E-02 | 4 | P10415, P04637, Q9UJU2, P24522 | BCL2, TP53, LEF1, GADD45A | More | | Dotatate-gallium-Ga-68 | hsa05212 | Pancreatic cancer | 3.40E-02 | 1 | P37173 | TGFBR2 | More | | Dotatate-gallium-Ga-68 | hsa05213 | Endometrial cancer | 1.91E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Dotatate-gallium-Ga-68 | hsa05215 | Prostate cancer | 1.94E-02 | 4 | P10415, Q9UJU2, Q09472, P04637 | BCL2, LEF1, EP300, TP53 | More | | Dotatate-gallium-Ga-68 | hsa05216 | Thyroid cancer | 5.28E-03 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Dotatate-gallium-Ga-68 | hsa05217 | Basal cell carcinoma | 1.34E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Dotatate-gallium-Ga-68 | hsa05222 | Small cell lung cancer | 1.94E-02 | 4 | P10415, Q13077, P04637, P24522 | BCL2, TRAF1, TP53, GADD45A | More | | Dotatate-gallium-Ga-68 | hsa05224 | Breast cancer | 4.32E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Dotatate-gallium-Ga-68 | hsa05226 | Gastric cancer | 8.86E-03 | 5 | Q9UJU2, P04637, P24522, P14923, P10415 | LEF1, TP53, GADD45A, JUP, BCL2 | More | | Dotatate-gallium-Ga-68 | hsa05230 | Central carbon metabolism in cancer | 4.04E-02 | 2 | P07195, P04637 | LDHB, TP53 | More | | Dotatate-gallium-Ga-68 | hsa05321 | Inflammatory bowel disease | 2.22E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Dotatate-gallium-Ga-68 | hsa05332 | Graft-versus-host disease | 2.76E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | |